-
FINRA disciplinary action update 2025/47
Disciplinary decisions issued December 13 – 20, 2025.
-
A transformational 2025 in US healthcare – and more to come in 2026
In many ways, 2025 found the healthcare sector at a crossroads, with compliance officers holding their heads.
-
UK financial services regulation: 2025 trends and the 2026 outlook
Supervision, enforcement, and the need to embrace outcomes-focused conduct.
-
ASIC roundup: Court upholds A$250m penalty on ASX, Netwealth to pay over A$100m in compensation
The Australian Securities and Investments Commission’s latest actions and news, December 15 – 19, 2025.
-
What we learned from the DOJ’s year in enforcement
A new direction of travel has become clearer, which makes anticipating what happens next easier.
-
Swedish FSA fines Svea Bank SKr170m for violating money-laundering regulations
The regulator’s investigation turned up deficiencies in the bank’s risk assessments and customer due diligence measures.
-
Bill to limit US biotech companies doing business with China advances
The new bill would have government agencies referring to the Department of Defense’s 1260H list of Chinese military companies operating in the US.
-
FDA turns focus on biologics in spate of warning letters
The three letters point to an enforcement posture toward manufacturers marketing biologics derived from human placentas and umbilical cords.